QQQ   426.68 (-1.03%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   426.68 (-1.03%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   426.68 (-1.03%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   426.68 (-1.03%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)

IDEXX Laboratories (IDXX) Competitors

$479.21
-10.36 (-2.12%)
(As of 12:14 PM ET)

IDXX vs. TAK, MRNA, IQV, ALC, GEHC, CNC, COR, HUM, HLN, and VEEV

Should you be buying IDEXX Laboratories stock or one of its competitors? The main competitors of IDEXX Laboratories include Takeda Pharmaceutical (TAK), Moderna (MRNA), IQVIA (IQV), Alcon (ALC), GE HealthCare Technologies (GEHC), Centene (CNC), Cencora (COR), Humana (HUM), Haleon (HLN), and Veeva Systems (VEEV). These companies are all part of the "medical" sector.

IDEXX Laboratories vs.

IDEXX Laboratories (NASDAQ:IDXX) and Takeda Pharmaceutical (NYSE:TAK) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability, community ranking, media sentiment and earnings.

IDEXX Laboratories presently has a consensus target price of $591.50, indicating a potential upside of 20.82%. Takeda Pharmaceutical has a consensus target price of $14.00, indicating a potential upside of 5.74%. Given IDEXX Laboratories' higher possible upside, equities research analysts plainly believe IDEXX Laboratories is more favorable than Takeda Pharmaceutical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IDEXX Laboratories
0 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.67
Takeda Pharmaceutical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

IDEXX Laboratories has a beta of 1.26, meaning that its stock price is 26% more volatile than the S&P 500. Comparatively, Takeda Pharmaceutical has a beta of 0.53, meaning that its stock price is 47% less volatile than the S&P 500.

87.8% of IDEXX Laboratories shares are owned by institutional investors. Comparatively, 9.2% of Takeda Pharmaceutical shares are owned by institutional investors. 2.2% of IDEXX Laboratories shares are owned by insiders. Comparatively, 0.0% of Takeda Pharmaceutical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, IDEXX Laboratories had 1 more articles in the media than Takeda Pharmaceutical. MarketBeat recorded 4 mentions for IDEXX Laboratories and 3 mentions for Takeda Pharmaceutical. IDEXX Laboratories' average media sentiment score of 1.13 beat Takeda Pharmaceutical's score of -0.23 indicating that IDEXX Laboratories is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IDEXX Laboratories
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Takeda Pharmaceutical
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

IDEXX Laboratories has a net margin of 23.08% compared to Takeda Pharmaceutical's net margin of 6.90%. IDEXX Laboratories' return on equity of 71.66% beat Takeda Pharmaceutical's return on equity.

Company Net Margins Return on Equity Return on Assets
IDEXX Laboratories23.08% 71.66% 28.11%
Takeda Pharmaceutical 6.90%12.57%5.89%

IDEXX Laboratories received 423 more outperform votes than Takeda Pharmaceutical when rated by MarketBeat users. Likewise, 72.64% of users gave IDEXX Laboratories an outperform vote while only 56.82% of users gave Takeda Pharmaceutical an outperform vote.

CompanyUnderperformOutperform
IDEXX LaboratoriesOutperform Votes
523
72.64%
Underperform Votes
197
27.36%
Takeda PharmaceuticalOutperform Votes
100
56.82%
Underperform Votes
76
43.18%

Takeda Pharmaceutical has higher revenue and earnings than IDEXX Laboratories. Takeda Pharmaceutical is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IDEXX Laboratories$3.66B11.11$845.04M$10.0748.62
Takeda Pharmaceutical$4.17T0.01$2.35B$0.6620.06

Summary

IDEXX Laboratories beats Takeda Pharmaceutical on 15 of the 17 factors compared between the two stocks.

Get IDEXX Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for IDXX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IDXX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IDXX vs. The Competition

MetricIDEXX LaboratoriesDiagnostic substances IndustryMedical SectorNASDAQ Exchange
Market Cap$40.66B$2.58B$4.72B$7.49B
Dividend YieldN/AN/A5.48%3.96%
P/E Ratio48.62213.19267.7819.08
Price / Sales11.11115.392,591.9387.71
Price / Cash43.0714.5133.5528.11
Price / Book27.383.684.674.27
Net Income$845.04M$584,090.91$100.91M$211.64M
7 Day Performance-2.89%-5.52%-4.00%-3.76%
1 Month Performance-7.59%-8.73%-3.67%-2.68%
1 Year Performance1.67%-31.32%11.42%5.86%

IDEXX Laboratories Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TAK
Takeda Pharmaceutical
0.253 of 5 stars
$13.65
-0.1%
$14.00
+2.6%
-21.2%$43.20B$29.81B20.6849,095
MRNA
Moderna
3.8823 of 5 stars
$111.60
+6.2%
$129.82
+16.3%
-33.9%$42.73B$6.85B-8.995,600High Trading Volume
IQV
IQVIA
4.9154 of 5 stars
$245.33
+1.6%
$256.80
+4.7%
+14.4%$44.53B$14.98B33.6587,000Short Interest ↓
Positive News
ALC
Alcon
2.3657 of 5 stars
$82.68
-1.4%
$90.49
+9.4%
+10.8%$40.77B$9.46B42.1825,000Short Interest ↑
GEHC
GE HealthCare Technologies
4.0446 of 5 stars
$86.94
-0.9%
$93.92
+8.0%
+4.3%$39.67B$19.55B28.7951,000Upcoming Earnings
CNC
Centene
4.7896 of 5 stars
$72.70
-0.4%
$85.08
+17.0%
+6.2%$38.89B$154.00B14.8167,700Analyst Report
Short Interest ↓
Positive News
COR
Cencora
3.6976 of 5 stars
$238.57
-0.7%
$218.22
-8.5%
+42.6%$47.59B$262.17B25.9946,000
HUM
Humana
4.9992 of 5 stars
$319.62
+0.8%
$465.42
+45.6%
-39.4%$38.56B$106.37B16.1367,600Upcoming Earnings
Gap Up
HLN
Haleon
1.205 of 5 stars
$8.30
+1.0%
N/A-8.2%$37.90B$14.05B29.6425,408Positive News
VEEV
Veeva Systems
4.7231 of 5 stars
$216.54
+0.7%
$234.90
+8.5%
+12.0%$34.68B$2.36B67.257,172

Related Companies and Tools

This page (NASDAQ:IDXX) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners